Product Information
DEXTROAMP-AMPHET ER 30 MG CAP is a generic product labeled by SpecGx LLC, priced at $0.4689 per EA under NDC 00406895601. Its NADAC has been published 376 times since Jun 12, 2019.
FDA first approved this application on Apr 22, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 30 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine SulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
SpecGx LLCNDC
00406895601
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA211547FDA Approved
4/22/2019
TE Code
AB1
On Market Since
4/22/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has been published 376 times since Jun 12, 2019, and over the history we have for it it has declined 74.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4689 per EA |
|---|---|
| All-time high | $1.9728 (Aug 14, 2019) |
| All-time low | $0.3360 (May 22, 2024) |
| 52-week high | $0.5895 |
| 52-week low | $0.4621 |
| Median price | $0.6435 |
| Average price | $0.8081 |
| Largest weekly change | +61.4% (Jun 19, 2024) |
| Weeks tracked | 376 |
| Tracking since | Jun 12, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 30 MG CAP, manufactured by SpecGx LLC, is $0.4689 per EA (NDC 00406895601), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHET ER 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has declined 74.4%. It has been tracked across 376 weekly CMS publications since Jun 12, 2019.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 30 MG CAP?
Since Jun 12, 2019, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has ranged from a low of $0.3360 (May 22, 2024) to a high of $1.9728 (Aug 14, 2019), with a median of $0.6435 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 30 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHET ER 30 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHET ER 30 MG CAP?
DEXTROAMP-AMPHET ER 30 MG CAP (NDC 00406895601) is labeled by SpecGx LLC, and CMS classifies it as a generic product.